Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check64 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the meaning.SummaryDifference1.0%
- Check72 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.6%
Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.